Trish Stroman
About Trish
Trish is a principal in BCG's Washington office and a core member of the firm's Health Care practice, with a focus on global public health.

Trish Stroman

May 15, 2012

Burma: Malaria’s Crucial Battleground

The emergence of parasites resistant to artemisinin—the gold-standard drug for treating malaria—poses a threat to global health. Left unchecked, a drug-resistant strain could spread to India and Africa. In The Wall Street Journal Asia, BCG’s Trish Stroman and Harvard’s Jay Winsten explain why Burma is key to containing the spread of artemisinin resistance.

> More
January 14, 2011

Malaria: Responding to the Urgent Threat of Drug Resistance

Despite recent progress, the war on malaria is far from won. The emergence of drug-resistant strains of the disease will require advocacy and political commitment at the highest levels—and funding for prevention, diagnosis, treatment, and research efforts.
> More